Dianthus Therapeutics, Inc. /DE/ Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2024.
  • Dianthus Therapeutics, Inc. /DE/ Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $218M.
  • Dianthus Therapeutics, Inc. /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2023 was $134M, a 38.2% increase from 2022.
  • Dianthus Therapeutics, Inc. /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2022 was $96.7M, a 548% increase from 2021.
  • Dianthus Therapeutics, Inc. /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2021 was $14.9M, a 78% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $218M +$218M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $0 -$418K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $418K -$706K -62.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $1.12M +$561K +99.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $563K +$738K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 -$175K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.